Biotech start-up Normunity, Inc. has exited stealth with a $65 million Series A to create a new class of medicines that target novel I-O mechanisms, which free the body’s normal immunity against ...

April 14, 2026 • House Ethics Committee member Rep. Suhas Subramanyam and law professor Richard Painter break down why controversy might have forced Representatives Eric Swalwell and Tony Gonzales to ...

Team Cherry's first video game is so iconic thanks to these ten Hollow Knight mechanics that make the game unique from most ...